Showing results (251-260 of 335) with videos related to
Sort By:
Pageof 34
Histopathology|September 1, 1995
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinomaH Pereira, S E Pinder, D M Sibbering, et al.British Journal of Cancer|October 1, 1987
Confirmation of a prognostic index in primary breast cancerJ H Todd, C Dowle, M R Williams, et al.International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.Anticancer Research|May 1, 1997
Male breast cancer: pathological and immunohistochemical featuresP C Willsher, I H Leach, I O Ellis, et al.British Journal of Cancer|September 1, 1987
Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinomaI O Ellis, J Bell, J M Todd, et al.Histopathology|March 26, 2003
Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3)A H S Lee, H E Denley, S E Pinder, et al.British Journal of Cancer|March 13, 2014
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancerE A Rakha, D Soria, A R Green, et al.Breast Cancer Research and Treatment|December 5, 1997
Predictors of response to second-line endocrine therapy for breast cancerK L Cheung, P C Willsher, S E Pinder, et al.Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.British Journal of Cancer|July 10, 2008
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeS E Elsheikh, A R Green, E A Rakha, et al.Pageof 34